LSX World Congress 2020 What is it and who is it for?
Peer-to-peer discussion, high-level networking and partnering, unique conference formats and a vetted, high-calibre audience
Peer-to-peer discussion, high-level networking and partnering, unique conference formats and a vetted, high-calibre audience
Antimicrobial resistance is one of the most serious threats to humanity. This year, a staggering 700,000 people will die from infections that cannot be treated by most or all available antibiotics.
Insights from Optimum’s 11th Annual Healthcare Investor Conference, looking ahead at ‘the next big thing that may transform patient care’ in 2020
Mary Clark and Shabnam Bashir will be at the 38th Annual J.P. Morgan Healthcare Conference on 13-16 January 2020 in San Francisco
Insightful interview into the work of Entrepeneur In Residence, Dr Christian Schetter of Arix Bioscience
Chaired by Tara Raveendran of Shore Capital. Speakers from Asceneuron, Storm Therapeutics, Theragnostics & Macrophage.
We are thrilled to see our excellent clients recognised at this years Scrip Awards 2019
Strategy, investment, partnering and deal-making for global digital health leaders
Full Agenda & Speakers announced for Optimum’s Healthcare Investor Conference on 17th October 2019! Register free now!
Renee Aguiar-Lucander, CEO of Calliditas Therapeutics interviewed as part of Labiotech’s #WomenInBiotech series.
Catherine Pickering of iOnctura, interviewed as part of Labiotech’s #WomenInBiotech series
Galapagos NV in collaboration with Gilead to create a global R&D leader based in Europe
Optimum’s 11th Annual Healthcare Investor Conference 2019 at Bloomberg. Pop it in the diary now!
“New technologies like RNA inhibitors that alter the genetic drivers of a disease, have the potential to transform medicine…”
Listen to Ixico’s interview on Vox Market’s daily podcast with Justin Waite. Forward to 23:00 minutes to hear them discuss their growth…
Niall Martin is on a mission to put DNA repair on the map. He has already gone pretty far along the way to doing this, as the leader of the … Continue reading “Artios Pharma CEO, Niall Martin is on a mission to put DNA repair on the map”
Click this link to register and listen to the insightful podcast from Verona Pharma’s Investor and Analyst R&D Day forum 2019
Continuing Cambridge’s tradition as a centre of excellence for DNA Damage Response with leading next generation programmes.
Arix Bioscience (ARIX) CEO Joe Anderson talked to VoxMarkets about investing in and building breakthrough biotech companies to market.
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...
GET IN TOUCH
© Copyright 2020 Optimum Strategic Communications All rights reserved.
Warnford Court
29 Throgmorton Street
London
EC2M 4PL
Tel: +44 (0)203 950 9144
Email: contact@optimumcomms.com